Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma

The proteoglycan versican (VCAN) promotes tumor progression and enhances metastasis in several cancers; however, its role in clear cell renal cell carcinoma (ccRCC) remains unknown. Recent evidence suggests that VCAN is an important target of chromosomal 5q gain, one of the most prevalent genetic ab...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cancer Res
Hlavní autoři: Mitsui, Yozo, Shiina, Hiroaki, Kato, Taku, Maekawa, Shigekatsu, Hashimoto, Yutaka, Shiina, Marisa, Imai-Sumida, Mitsuho, Kulkarni, Priyanka, Dasgupta, Pritha, Wong, Ryan Kenji, Hiraki, Miho, Arichi, Naoko, Fukuhara, Shinichiro, Yamamura, Soichiro, Majid, Shahana, Saini, Sharanjot, Deng, Guoren, Dahiya, Rajvir, Nakajima, Koichi, Tanaka, Yuichiro
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890926/
https://ncbi.nlm.nih.gov/pubmed/28242813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-16-0444
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky